Variant report
Variant | esv3326185 |
---|---|
Chromosome Location | chr6:160697102-160699384 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:61)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr6:160697599-160697782 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | ZNF143 | chr6:160698623-160698778 | H1-hESC | embryonic stem cell: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:160697625-160697675 | SK-N-SH | brain: | n/a |
2 | chr6:160697625-160697675 | NHBE | bronchial: | n/a |
3 | chr6:160697625-160697675 | SKMC | muscle: | n/a |
4 | chr6:160697625-160697675 | HCPEpiC | choroid plexus: | n/a |
5 | chr6:160697625-160697675 | PrEC | prostate: | n/a |
6 | chr6:160697625-160697675 | AG04449 | skin: | fetal |
7 | chr6:160697625-160697675 | GM12878 | blood: | n/a |
8 | chr6:160697625-160697675 | HRPEpiC | eye: | n/a |
9 | chr6:160697625-160697675 | GM12892 | blood: | n/a |
10 | chr6:160697625-160697675 | NH-A | brain: | n/a |
11 | chr6:160697625-160697675 | BJ | skin: | n/a |
12 | chr6:160697625-160697675 | ECC-1 | luminal epithelium: | n/a |
13 | chr6:160697625-160697675 | Hepatocyte | liver: | n/a |
14 | chr6:160697625-160697675 | HepG2 | liver: | n/a |
15 | chr6:160697625-160697675 | H1-hESC | embryonic stem cell: | embryo |
16 | chr6:160697625-160697675 | A549 | lung: | n/a |
17 | chr6:160697625-160697675 | RPTEC | kidney: | n/a |
18 | chr6:160697625-160697675 | HRE | kidney: | n/a |
19 | chr6:160697625-160697675 | SK-N-SH_RA | brain: | n/a |
20 | chr6:160697625-160697675 | U87 | brain: | n/a |
21 | chr6:160697625-160697675 | HCM | heart: | n/a |
22 | chr6:160697625-160697675 | MCF-7 | breast: | n/a |
23 | chr6:160697625-160697675 | PANC-1 | pancreas: | n/a |
24 | chr6:160697625-160697675 | ProgFib | skin: | n/a |
25 | chr6:160697625-160697675 | GM12891 | blood: | n/a |
26 | chr6:160697625-160697675 | MCF10A-Er-Src | breast: | n/a |
27 | chr6:160697625-160697675 | HNPCEpiC | eye: | n/a |
28 | chr6:160697625-160697675 | HUVEC | blood vessel: | n/a |
29 | chr6:160697625-160697675 | GM06990 | blood: | n/a |
30 | chr6:160697625-160697675 | HRCEpiC | kidney: | n/a |
31 | chr6:160697625-160697675 | ovcar-3 | ovarian: | n/a |
32 | chr6:160697625-160697675 | Jurkat | blood: | n/a |
33 | chr6:160697625-160697675 | HPAEpiC | pulmonary alveolar: | n/a |
34 | chr6:160697625-160697675 | K562 | blood: | n/a |
35 | chr6:160697625-160697675 | AG04450 | lung: | fetal |
36 | chr6:160697625-160697675 | AG10803 | skin: | n/a |
37 | chr6:160697625-160697675 | NHDF-neo | bronchial: | n/a |
38 | chr6:160697625-160697675 | Hela-S3 | cervix: | n/a |
39 | chr6:160697625-160697675 | LNCaP | prostate: | n/a |
40 | chr6:160697625-160697675 | IMR90 | lung: | fetal |
41 | chr6:160697625-160697675 | Caco-2 | colon: | n/a |
42 | chr6:160697625-160697675 | SAEC | small airway: | n/a |
43 | chr6:160697625-160697675 | GM19239 | blood: | n/a |
44 | chr6:160697625-160697675 | CMK | blood: | n/a |
45 | chr6:160697625-160697675 | PFSK-1 | brain: | n/a |
46 | chr6:160697625-160697675 | HL-60 | blood: | n/a |
47 | chr6:160697625-160697675 | AG09319 | gingival: | n/a |
48 | chr6:160697625-160697675 | T-47D | breast: | n/a |
49 | chr6:160697625-160697675 | SK-N-MC | brain: | n/a |
50 | chr6:160697625-160697675 | HMEC | breast: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:160692844..160695658-chr6:160695903..160698267,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SLC22A3-1 | chr6:160696793-160697162 | ENSG00000230234 |
No data |
No data |
Variant related genes | Relation type |
---|---|
SLC22A2 | TF binding region |
SLC22A2 | CpG island |
ENSG00000230234 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537872610 | chr6:160697104-160697105 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs377377510 | chr6:160697132-160697133 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs554336935 | chr6:160697136-160697137 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs574489590 | chr6:160697164-160697165 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs534084765 | chr6:160697199-160697200 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs2297213 | chr6:160697208-160697209 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs531058827 | chr6:160697209-160697210 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs554398720 | chr6:160697211-160697212 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs115826818 | chr6:160697228-160697229 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs546082148 | chr6:160697238-160697239 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs574404559 | chr6:160697251-160697252 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs543571834 | chr6:160697252-160697253 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs576337817 | chr6:160697292-160697293 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs316036 | chr6:160697306-160697307 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs562008050 | chr6:160697309-160697310 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs187609582 | chr6:160697324-160697325 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs2297212 | chr6:160697325-160697326 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs113078293 | chr6:160697328-160697329 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs546940742 | chr6:160697345-160697346 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs369123117 | chr6:160697405-160697406 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs191023278 | chr6:160697427-160697428 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs183540784 | chr6:160697457-160697458 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs375161746 | chr6:160697478-160697479 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs569152323 | chr6:160697488-160697489 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs138042398 | chr6:160697517-160697518 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs57187107 | chr6:160697604-160697605 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs548175754 | chr6:160697620-160697621 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs368318859 | chr6:160697626-160697627 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs532440 | chr6:160697628-160697629 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs370448843 | chr6:160697686-160697687 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs553493293 | chr6:160697700-160697701 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs533452 | chr6:160697762-160697763 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs557168633 | chr6:160697765-160697766 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs539673279 | chr6:160697804-160697805 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs556551569 | chr6:160697815-160697816 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs189094311 | chr6:160697856-160697857 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs80067594 | chr6:160697866-160697867 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs555728713 | chr6:160697876-160697877 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs192151291 | chr6:160697923-160697924 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs541522356 | chr6:160697929-160697930 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs564598751 | chr6:160697971-160697972 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs62442376 | chr6:160697974-160697975 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs567926390 | chr6:160697976-160697977 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs532315406 | chr6:160697989-160697990 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs569100211 | chr6:160698001-160698002 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs545991749 | chr6:160698036-160698037 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs368707281 | chr6:160698045-160698046 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs149529072 | chr6:160698111-160698112 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs146023512 | chr6:160698146-160698147 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs3127578 | chr6:160698155-160698156 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17850661 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 20556506 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 19459884 | CNVD |
Hearing loss | 19459884 | CNVD |
Microcephaly | 19459884 | CNVD |
Coronary artery disease | 17160897 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:160695800-160698800 | Enhancers | Fetal Muscle Leg | muscle |
2 | chr6:160696600-160698800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr6:160696800-160697200 | Enhancers | Brain Anterior Caudate | brain |
4 | chr6:160696800-160697200 | Enhancers | Placenta | Placenta |
5 | chr6:160696800-160697400 | Enhancers | Brain Substantia Nigra | brain |
6 | chr6:160696800-160697600 | Enhancers | H1 Cell Line | embryonic stem cell |
7 | chr6:160696800-160698600 | Enhancers | Psoas Muscle | Psoas |
8 | chr6:160697000-160697200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr6:160697000-160697200 | Enhancers | Liver | Liver |
10 | chr6:160697000-160698400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
11 | chr6:160697000-160698600 | Weak transcription | Gastric | stomach |
12 | chr6:160697000-160698800 | Flanking Active TSS | Skeletal Muscle Male | skeletal muscle |
13 | chr6:160697000-160699000 | Enhancers | Fetal Muscle Trunk | muscle |
14 | chr6:160697600-160700000 | Weak transcription | H1 Cell Line | embryonic stem cell |
15 | chr6:160698200-160699200 | Enhancers | Fetal Brain Male | brain |
16 | chr6:160698400-160698800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
17 | chr6:160698400-160698800 | Flanking Active TSS | Skeletal Muscle Female | skeletal muscle |
18 | chr6:160698600-160700000 | Weak transcription | Psoas Muscle | Psoas |
19 | chr6:160698800-160699600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
20 | chr6:160698800-160699600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
21 | chr6:160698800-160699800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |